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Number of patients currently in treatment:
~ 1.4 million worldwide  USA: ~ 360,000  Europe: ~ 600,000  Rest of world: ~400,000
Efficacy in "good" methadone treatment programs using adequate doses (80 to 150mg/d): Voluntary retention in treatment (1 year or more) 60 -80%
Continuing use of illicit heroin 5 -20%
Actions of methadone treatment:
 Prevents withdrawal symptoms and "drug hunger"  Blocks euphoric effects of short-acting narcotics  Allows normalization of disrupted physiology
Mechanism of action:
Long-acting medication (24h half-life for racemate in humans) provides steady levels of opioid at specific receptor sites.
 methadone found to be a full mu opioid receptor agonist which internalizes like endorphins (beta-endorphin and enkephalins)  methadone also has modest NMDA receptor complex antagonism Kreek, 1972; 1973; 2019 
